Home > Insider Trading > Filing (0001708138-17-000005)

Filing Details

Accession Number:: 0001708138-17-000005
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2017-06-16 16:36:59
Reporting Period:: 2017-06-14

Filing Date:: 2017-06-16
Accepted Time:: 2017-06-16 16:36:59
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
872589	Regeneron Pharmaceuticals Inc	REGN	Pharmaceutical Preparations (2834)	133444607

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1226689	Neil Stahl	777 Old Saw Mill River Road Tarrytown NY 10591	Evp Research And Development	No	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Acquisiton	2017-06-14	20,295	$21.25	44,245	No	4	M	Direct
Common Stock	Disposition	2017-06-14	906	$475.56	43,339	No	4	F	Direct
Common Stock	Disposition	2017-06-14	10,822	$475.56	32,517	No	4	F	Direct
Common Stock	Disposition	2017-06-15	500	$462.72	32,017	No	4	S	Direct
Common Stock	Disposition	2017-06-15	100	$463.91	31,917	No	4	S	Direct
Common Stock	Disposition	2017-06-15	400	$464.69	31,517	No	4	S	Direct
Common Stock	Disposition	2017-06-15	1,244	$465.49	30,273	No	4	S	Direct
Common Stock	Disposition	2017-06-15	185	$466.52	30,088	No	4	S	Direct
Common Stock	Disposition	2017-06-15	300	$467.82	29,788	No	4	S	Direct
Common Stock	Disposition	2017-06-15	900	$468.63	28,888	No	4	S	Direct
Common Stock	Disposition	2017-06-15	2,212	$469.53	26,676	No	4	S	Direct
Common Stock	Disposition	2017-06-15	2,426	$470.57	24,250	No	4	S	Direct
Common Stock	Disposition	2017-06-15	100	$471.15	24,150	No	4	S	Direct
Common Stock	Disposition	2017-06-15	100	$472.95	24,050	No	4	S	Direct
Common Stock	Disposition	2017-06-15	100	$474.48	23,950	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	M	Direct
No	4	F	Direct
No	4	F	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Non-Qualified Stock Option (right to buy)	Disposition	2017-06-14	20,295	$0.00	20,295	$21.25

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
0		2019-12-18	No	4	M	Direct

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	10,000	Indirect	by GRAT
Common Stock	5,000	Indirect	by GRAT
Common Stock	5,647	Indirect	By 401(k) Plan

Footnotes

Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c).
Represents volume-weighted average price of sales of 500 shares of Company stock on June 15, 2017 at prices ranging from $462.38 to $462.97. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on June 15, 2017 at each separate price.
Represents volume-weighted average price of sales of 400 shares of Company stock on June 15, 2017 at prices ranging from $464.46 to $464.87. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on June 15, 2017 at each separate price.
Represents volume-weighted average price of sales of 1,244 shares of Company stock on June 15, 2017 at prices ranging from $465.00 to $465.98. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on June 15, 2017 at each separate price.
Represents volume-weighted average price of sales of 185 shares of Company stock on June 15, 2017 at prices ranging from $466.49 to $466.55. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on June 15, 2017 at each separate price.
Represents volume-weighted average price of sales of 300 shares of Company stock on June 15, 2017 at prices ranging from $467.70 to $467.96. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on June 15, 2017 at each separate price.
Represents volume-weighted average price of sales of 900 shares of Company stock on June 15, 2017 at prices ranging from $468.00 to $468.97. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on June 15, 2017 at each separate price.
Represents volume-weighted average price of sales of 2,212 shares of Company stock on June 15, 2017 at prices ranging from $469.07 to $469.97. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on June 15, 2017 at each separate price.
Represents volume-weighted average price of sales of 2,426 shares of Company stock on June 15, 2017 at prices ranging from $470.03 to $470.98. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on June 15, 2017 at each separate price.
The stock option award (combined incentive stock option and non-qualified stock option) vests in four equal annual installments, commencing one year after the date of grant.